Fluorescent Dye for Cancer Margin Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current surgical methods for skin cancer treatment face challenges in accurately identifying the boundaries of cancerous tissue, leading to potential incomplete removal and the need for additional surgeries.

Innovation Solution

A surgical system and method utilizing a cancer identifying fluid that emits visible light when contacting cancerous tissue and exposed to ultraviolet light, allowing for the visualization of positive margins during surgery, ensuring complete tissue removal in a single procedure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If the section of tissue removed is minimized to mitigate surgical impact, then patient recovery is improved, but the risk of incomplete cancerous tissue removal increases

Engineering Contradiction:
Improvesurgical impact on patientVSAvoidcompleteness of cancerous tissue removal
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies fluorescent dyes that change color or emit light when contacting cancerous tissue. The dye penetrates tissue and binds to cancer cells, causing them to fluoresce under specific lighting conditions. This allows surgeons to visually distinguish cancerous tissue boundaries in real-time, enabling precise removal of only the necessary tissue while ensuring complete cancerous tissue excision.

Inventive Principle:
Principle #32Color changes

2Reliability

If the tissue removal margin is expanded to ensure complete cancerous tissue removal, then treatment efficacy is improved, but the amount of healthy tissue removed increases

Engineering Contradiction:
Improvecompleteness of cancerous tissue removalVSAvoidamount of healthy tissue removed
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The fluorescent dye selectively accumulates in cancerous tissue and emits light when exposed to specific wavelengths. This optical contrast allows surgeons to precisely identify the exact boundaries of cancerous tissue, removing only the necessary margin while preserving adjacent healthy tissue that does not exhibit fluorescence.

Inventive Principle:
Principle #32Color changes

3Measurement precision

If intraoperative identification of cancerous tissue boundaries is improved, then surgical precision is improved, but the complexity of the surgical system increases

Engineering Contradiction:
Improveidentification accuracy of cancerous tissue boundariesVSAvoidsurgical system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system uses fluorescent dyes with specific excitation and emission wavelengths. A portable UV or blue light source excites the dye in cancerous tissue, causing it to emit visible light. This simple optical mechanism provides real-time visual feedback without requiring complex imaging equipment, maintaining surgical system simplicity while achieving high boundary identification accuracy.

Inventive Principle:
Principle #32Color changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates rapid identification and removal of all cancerous tissue, reducing the risk of residual cancer and eliminating the need for secondary surgeries, thereby improving treatment efficacy and patient outcomes.

Implementation Method 1

a cancer identifying fluid that is configured to emit light in response to the cancer identifying fluid both (a) contacting the cancerous cells and (b) being exposed to an activation light

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20240230654A1Systems and methods for identifying cancerous tissue
Publication Date: 2024.07.11 ERICSON CALEB
  • US20240230654A1 patent drawing
  • US20240230654A1 patent drawing
  • US20240230654A1 patent drawing

AI summary

A surgical system for identifying cancerous tissue includes a dish configured to receive a tissue sample, a frame including a base defining a recess configured to receive the dish, an upright extending upward from the base, and an overhang extending over the base, and a light source coupled to the overhang and positioned to emit light toward the recess.